Oncotelic Therapeutics, Inc. has successfully completed the initial safety cohort study of its Phase 1B SP-03-B101 clinical trial.
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
It is worth noting that an independent safety review committee has reviewed relevant data and officially recommended proceeding to the next phase of dose escalation research. Meanwhile, the company is actively promoting the expansion of this trial in Europe, marking an important advancement in its research and development pipeline.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
MSCI Drops Strategy From Its US Index: Will $2.8 Billion in Forced Selling Hit MSTR?
BeInCrypto•2026/11/11 22:48
UK growth figures are next for a Pound at a three-week low
FXStreet•2026/11/11 22:45
Crypto prices
More
Bitcoin
BTC
$73,850.08
+0.24%
Ethereum
ETH
$2,053.56
+0.29%
Tether USDt
USDT
$0.9988
-0.01%
BNB
BNB
$682.23
+0.70%
USDC
USDC
$0.9997
-0.01%
XRP
XRP
$1.05
-0.38%
Solana
SOL
$83.38
+0.54%
TRON
TRX
$0.3171
-0.14%
Hyperliquid
HYPE
$71.64
-0.83%
Zcash
ZEC
$977.13
-6.74%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now